During the American Society of Nephrology’s 43rd Annual Meeting and Scientific Exposition, researchers at Technion-Israel Institute of Technology, in Haifa, Israel reported their results in patients with chronic kidney disease.
First, the details.
101 dialysis patients were assigned to a treatment group for 1 year.
Pomegranate juice at the beginning of each dialysis session, 3 times a week
A placebo drink
And, the results.
There was laboratory evidence that patients who drank pomegranate juice had reduced inflammation, and damage of oxidative stress was minimized.
Pomegranate juice drinkers were less likely to be hospitalized due to infections.
Those who drank pomegranate juice also showed an improvement in cardiovascular risk factors, such as reduced blood pressure, improvement in lipid profile, and fewer cardiovascular events (eg, heart attack).
The bottom line?
We look forward to reading the published article, which should have greater detail.
John Russo, Jr., PharmD, is president of The MedCom Resource, Inc. Previously, he was senior vice president of medical communications at www.Vicus.com, a complementary and alternative medicine website.